CANF
Can-Fite Biopharma
$1.66
+$0.01 (+0.61%)Oct 29, 2026
Key metrics
The numbers that frame CANF today
- Market cap
- $3.56M
- EV / Sales
- 1.5
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.61
- 52wk High
- $12.30
Growth
Revenue and earnings trend for CANF
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CANF
Is Can-Fite Biopharma a good buy?
No. Can-Fite Biopharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Can-Fite Biopharma is selling at a very high price.
What is the market capitalization of CANF?
Can-Fite Biopharma's market capitalization is $3.56M.
What is the 52-week high for CANF stock?
The 52-week high for Can-Fite Biopharma is $12.30. The current close of $1.66 is 86.5% below that high.
What is the 52-week low for CANF stock?
The 52-week low for Can-Fite Biopharma is $1.61. The current close of $1.66 is 3.4% above that low.
Does CANF stock pay dividends?
Can-Fite Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CANF?
Can-Fite Biopharma's Debt / Equity ratio is 0.01.